- Home
- CRDF vs LDI Comparison
CRDF vs LDI Comparison
Compare CRDF & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- LDI
- Stock Information
- Founded
- CRDF 1999
- LDI 2010
- Country
- CRDF United States
- LDI United States
- Employees
- CRDF N/A
- LDI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- LDI Finance: Consumer Services
- Sector
- CRDF Health Care
- LDI Finance
- Exchange
- CRDF Nasdaq
- LDI Nasdaq
- Market Cap
- CRDF 233.5M
- LDI 221.2M
- IPO Year
- CRDF N/A
- LDI 2021
- Fundamental
- Price
- CRDF $2.32
- LDI $2.02
- Analyst Decision
- CRDF Strong Buy
- LDI Sell
- Analyst Count
- CRDF 6
- LDI 3
- Target Price
- CRDF $10.58
- LDI $2.30
- AVG Volume (30 Days)
- CRDF 2.9M
- LDI 1.9M
- Earning Date
- CRDF 07-29-2025
- LDI 08-07-2025
- Dividend Yield
- CRDF N/A
- LDI N/A
- EPS Growth
- CRDF N/A
- LDI N/A
- EPS
- CRDF N/A
- LDI N/A
- Revenue
- CRDF $545,000.00
- LDI $1,124,074,000.00
- Revenue This Year
- CRDF N/A
- LDI $26.92
- Revenue Next Year
- CRDF N/A
- LDI $15.27
- P/E Ratio
- CRDF N/A
- LDI N/A
- Revenue Growth
- CRDF N/A
- LDI 27.06
- 52 Week Low
- CRDF $2.09
- LDI $1.01
- 52 Week High
- CRDF $5.64
- LDI $3.23
- Technical
- Relative Strength Index (RSI)
- CRDF 34.12
- LDI 61.32
- Support Level
- CRDF $2.22
- LDI $1.81
- Resistance Level
- CRDF $2.56
- LDI $2.00
- Average True Range (ATR)
- CRDF 0.13
- LDI 0.18
- MACD
- CRDF 0.01
- LDI -0.00
- Stochastic Oscillator
- CRDF 25.64
- LDI 80.58
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.